A 28-year-old woman, G1P0 at weeks gestation, comes to the clinic for a routine prenatal follow-up. She has a 5-year history of systemic lupus erythematosus (SLE) that has been quiescent on hydroxychloroquine. She reports mild, generalized fatigue and occasionally feeling "out of breath" when climbing stairs, but she explicitly denies joint pain, facial rashes, fevers, or chest pain. Her blood pressure is , and her pulse is . Physical examination shows trace bilateral pedal edema but is otherwise unremarkable. Fetal heart tones are .
Laboratory studies show the following:
| Test | Result |
|---|---|
| Hemoglobin | |
| Leukocyte count | |
| Platelet count | |
| Serum creatinine | |
| Anti-dsDNA antibodies | Negative |
| Complement C3 and C4 | Normal |
Arterial blood gas analysis on room air reveals:
| Parameter | Result |
|---|---|
| pH | |
| PaCO | |
| HCO |
Urinalysis shows trace protein with no red blood cells or cellular casts. The patient is anxious and asks if her recent symptoms and laboratory abnormalities indicate that her autoimmune disease is worsening. Which of the following is the most appropriate next step in management?
- Continuation of current management and reassuranceAnswer
- BInitiation of high-dose oral prednisone therapy
- CAdministration of oral sodium bicarbonate
- DInitiation of oral furosemide therapy
- EInitiation of empiric broad-spectrum antibiotic therapy